This stands
vaccinology on its head and raises all sorts of new complications for research.
Not exact matches
Brad Spellberg's research interests are diverse, ranging from basic immunology and
vaccinology, to pure clinical and outcomes research, to process improvement work related to delivery of care, focusing
on safety net hospitals.
Spellberg is currently working
on the immunology,
vaccinology, and host defense against highly resistant Gram negative bacilli, including Acinetobacter and carbapenem - resistant Enterobacteriaceae infections.
In the context of the «European Training Programme in
Vaccinology «Fraunhofer IME will provide three different Training Modules including Assay Development and Validation, focused
on SPR technology, Process Development and scale up, as well as
on Requirements for GMP - production.
A specific focus of WBVR is research
on infection biology, immunology and
vaccinology of relevant veterinary and human, current and emerging infectious diseases.
Within the «European Training Programme in
Vaccinology «Fraunhofer IME will provide two - day Training Modules focusing
on three different topics.
E. Remarque: PhD in immunology and over 20 years of experience in
vaccinology, focusing
on how the immune system responds to polymorphic antigens.
The Jenner will provide 20 places
on each of 3 courses: a) basic immunology, b) vaccine clinical development and biomanufacturing, and c) human and veterinary
vaccinology.
As a part of VIOLIN, we have developed Vaxign, the first web - based publically available vaccine target design tool based
on bioinformatics analysis of genome sequences using the strategy of reverse
vaccinology.
A key program of VIOLIN is Vaxign, the first web - based publically available vaccine target design tool based
on bioinformatics analysis of genome sequences using the strategy of reverse
vaccinology.
As AMA1 malaria vaccines are evaluated in efficacy trials, the impact of genetic diversity of parasite antigens
on vaccine efficacy is likely to emerge as a critical problem requiring integration of methods and concepts drawn from molecular epidemiology, molecular evolution, immunology and structural
vaccinology [9], [13].
Jörg brings over 17 years» experience in drug discovery and development across key areas such as oncology, infectious diseases,
vaccinology, and autoimmunity, with a focus
on peptide and nucleic acid - based therapeutics.